C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
01/2003
01/02/2003	EP1268404A1 Malonamic acids and derivatives thereof as thyroid receptor ligands
01/02/2003	EP1268396A1 Diphenyl ether compounds useful in therapy
01/02/2003	EP1115716B1 2-phenylpyran-4-one derivatives
01/01/2003	CN1388119A Stereoselective preparation for chirality 1-aryl-and 1-heteroaryl-2-substituted-ethyl-2-amine
01/01/2003	CN1388114A Continuous preparation of internal-even photographic acid amides
01/01/2003	CN1097592C Slfonic acid amide derivatives with herbicides activity
12/2002
12/31/2002	US6500952 Processes for preparing aminophenylsulfonylureas, and intermediates therefor
12/31/2002	US6500924 Package for using antagonists of the vitronectin receptor alpha-v beta3 comprising a metalloproteinase polypeptide of given amino acid sequence; treating arthritis, rheumatoid arthritis, retinopathy and tumors
12/31/2002	US6500865 Sulfonamide derivatives
12/31/2002	US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases
12/31/2002	US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002	US6500812 Gastrointestinal disorders; antiinflammatory agents
12/31/2002	US6500802 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
12/27/2002	WO2002046181A3 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
12/27/2002	WO2001023352A9 Preparation of sulfonyl imine compounds
12/26/2002	US20020198388 Sulfonamides which are aspartyl protease inhibitors; well suited for inhibiting HIV-1 and HIV-2 protease activity
12/26/2002	US20020198245 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002	US20020198244 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/24/2002	US6498253 Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
12/24/2002	US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100819A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002060421A3 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
12/19/2002	WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002	WO2002042248A3 Naphthalene derivatives
12/19/2002	US20020193540 Ionically conducting materials, electrolytes and selective membranes
12/19/2002	US20020193499 Method for preparing imides from sulfonyl fluorides
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	DE10121003A1 Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen Anthranilic acid amides, processes for preparing, their use as a medicament as well as pharmaceutical compositions containing them
12/19/2002	CA2448764A1 N-arylphenylacetamide derivatives and pharmaceutical compositions containing the same
12/18/2002	EP1265887A2 Carbocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265886A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002	EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002	EP1265857A1 Sulfonamide derivatives
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265606A1 Cell adhesion inhibitors
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP0946502B1 Sulfonamide interleukin-beta converting enzyme inhibitors
12/18/2002	EP0859607B1 Guanidino protease inhibitors
12/17/2002	US6495701 Method for manufacturing tricyclic amino alcohol derivatives
12/17/2002	US6495604 Cycloalkene derivatives, process for producing the same, and use
12/17/2002	US6495546 Propanolamine derivatives
12/12/2002	WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	WO2002098847A1 Cycloalkenylsulfonamide derivatives
12/12/2002	WO2002098846A1 Sulfonamide derivatives
12/12/2002	WO2002098845A1 Compounds and methods for preparing methanesulfonamides
12/12/2002	WO2002098839A1 Biphenylcarboxamides and process for preparation thereof
12/12/2002	WO2002098424A1 Novel anti-infectives
12/12/2002	WO2002064552A8 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020187377 Reacting an aromatic diol with a disulfonylamine compound; membrane for fuel cell
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2447746A1 Cycloalkenylsulfonamide derivatives
12/12/2002	CA2446719A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	CA2446716A1 Sulfonamide derivatives
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1264707A2 Thermosensitive recording material and novel color developer compounds
12/11/2002	EP1263716A2 Amino acid derivatives as hiv aspartyl protease inhibitors
12/11/2002	EP1263712A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0805796B1 Cell adhesion inhibitors
12/11/2002	CN1384742A Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
12/11/2002	CN1095828C Antitumor 2-aminocarbonyl-1-2-bis (methylsulfonyl)-1-(substd.) hydrazines
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002	US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002	US6492394 Procollagen c-proteinase inhibitors; treating fibrotic diseases
12/10/2002	US6492363 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives
12/10/2002	US6492099 Method for purifying free-base p-phenylenediamine-type photographic color developers
12/10/2002	CA2046949C Process for preparing perfluoroalkoxysulphonic compounds
12/09/2002	WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
12/09/2002	CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	US20020183397 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
12/05/2002	US20020183393 Dihydroxy or dialkoxy substituted benzenesulfonamide derivatives useful for treating a disorder mediated by RhoC enzyme or protein
12/04/2002	EP1261630A2 Bacterial genes and proteins that are essential for cell viability and their uses
12/04/2002	EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002	EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
11/2002
11/28/2002	WO2002095393A2 Drug evolution: drug design at hot spots
11/28/2002	WO2002094776A2 Surfaces for covalent attachment of ligands
11/28/2002	WO2002094769A1 Solid reagent for sampling and derivatization of carbonyl compounds
11/28/2002	WO2002094768A2 Aza hydroxylated ethyl amine compounds
11/28/2002	WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002	WO2002094766A1 Phthalamide derivative, agricultural or horticultural insecticide, and use thereof
11/28/2002	WO2002079122A3 Methods of synthesizing phenol-containing compounds
11/28/2002	WO2001092219A1 Glycinamides
11/28/2002	WO2001092214A1 Carbamic acid esters as inhibitors of factor xa
11/28/2002	US20020177731 Reacting an amine with acid chloride
11/28/2002	DE10124867A1 New substituted (hetero)aryl-alkenes or -alkynes, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates

1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 177